Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

• Asıl Yazarlar: Xin P (Yazar), Li C (Yazar), Zheng Y (Yazar), Peng Q (Yazar), Xiao H (Yazar), Huang Y (Yazar), Zhu X (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Dove Medical Press, 2017-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Pengliang Xin, Chuntuan Li, Yan Zheng, Qunyi Peng, Huifang Xiao, Yuanling Huang, Xiongpeng Zhu Department of Haematology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Licheng, Quanzhou, Fujian Province, China Background: Phosphatidylinositol 3-kinase/Akt/mammalian target of ra...